News & Press

News & Press

 

ImpediMed is one of the fastest growing small companies on the ASX.
To stay up to date with all ImpediMed’s news and events please visit the
Newsroom on www.impedimed.com.

Press Releases

  • Oct 23,2017   Shipments of SOZO with L-Dex in the U.S – View PDF
  • Aug 14,2017   U.S. FDA 510(k) Clearance Issued for SOZO with L-DEX – View PDF
  • Aug 08,2017   First patient enrolled in SOZO CHF Trial at Scripps Health – View PDF
  • Jul 17,2017   ASX IPD Press Release SOZO 510k – View PDF
  • Jul 06,2017   ASX IPD Press Release L-Dex Recommended In Clinical Practice Guidelines – View PDF
  • Jun 21,2017   ASX IPD Press Release SOZO CE Mark – View PDF
  • May 18,2017   New L-Dex Study Shows Significant Reduction in Clinical Lymphoedema – View PDF
  • March 07,2017   Placement of first SOZO Unit – View PDF
  • Jan 17,2017   Director Retirement – View PDF
  • Jan 16,2017   Appendix B – View PDF

Logos

Press contact

Nick George
+1 760 585 2081
Ngeorge@impedimed.com